1-3 of 3
Jing Wang
Close
Sort by
Journal Articles

Epstein Barr virus–positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo

Xiaoshan Zhang, Ran Zhang, Chenghui Ren, Yi Xu, Shuhong Wu, Carrie Meng, Apar Pataer, Xingzhi Song, Jianhua Zhang, Yixin Yao, Hua He, Huiqin Chen, Wencai Ma, Jing Wang, Funda Meric-Bernstam, Richard E. Champlin, John V. Heymach, Cliona M. Rooney, Stephen G. Swisher, Ara A. Vaporciyan, Jack A. Roth, M. James You, Michael Wang, Bingliang Fang
Journal: Blood Advances
Blood Adv (2022) 6 (3): 891–901.
https://doi.org/10.1182/bloodadvances.2021006156
Published: 2022
Includes: Supplemental data
Journal Articles

Development and characterization of prototypes for in vitro and in vivo mouse models of ibrutinib-resistant CLL

Burcu Aslan, Gorkem Kismali, Lisa S. Chen, LaKesla R. Iles, Mikhila Mahendra, Michael Peoples, Mihai Gagea, Natalie W. Fowlkes, Xiaofeng Zheng, Jing Wang, Christopher P. Vellano, Joseph R. Marszalek, Maria Teresa Sabrina Bertilaccio, Varsha Gandhi
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3134–3146.
https://doi.org/10.1182/bloodadvances.2020003821
Published: 2021
Includes: Supplemental data
Journal Articles

A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation

Li Li, Han Chen, David Marin, Yuanxin Xi, Qi Miao, Jiangxing Lv, Pinaki Prosad Banerjee, Hila Shaim, May Daher, Rafet Basar, Nobuhiko Imahashi, Juan Jimenez, Bingqian Hu, Rohtesh S. Mehta, Lucila Nassif Kerbauy, Mecit Kaplan, Mayela Mendt, Gonca Ozcan, Elif Gokdemir, Mayra Hernandez Sanabria, Ye Li, Ken Chen, Jing Wang, Luis Muniz-Feliciano, Wei-Li Zhao, Richard E. Champlin, Elizabeth J. Shpall, Katayoun Rezvani
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4117–4130.
https://doi.org/10.1182/bloodadvances.2019000835
Published: 2019
Includes: Supplemental data